Company: FVN
Filing Date: 2025-03-27
Form Type: DRS/A
Source: 0001829126-25-002094
Chunk: 334

Company: Future Vision II Acquisition Corp.
Filing Date: 2025-03-27
Form: DRS/A
Chunk 334
---
 whose term of office expires shall be eligible for re-election at
a meeting of the shareholders or re-appointment by the directors. A director of New VIWO may be appointed by ordinary resolution or by
the directors. Any appointment may be to fill a vacancy or as an additional director.

As of the date of this
proxy statement/prospectus, New VIWO’s executive officers will consist of Fidel Yang and Eric Wu after the effectiveness of the
Business Combination. Additional executive officers may be appointed by the New VIWO board of directors and serve at the discretion of
the board of directors. New VIWO’s board of directors is authorized to nominate persons to the offices set forth in New VIWO’s
Amended and Restated Memorandum and Articles of Association as it deems appropriate. New VIWO’s Amended and Restated Memorandum
and Articles of Association provide that the directors may appoint any person, who need not be a director to any office that may be required
(including without limitation, for the avoidance of doubt, one or more chief executive officers, presidents, a chief financial officer,
a treasurer, vice-presidents, one or more assistant vice-presidents, one or more assistant treasurers and one or more assistant secretaries),
for such period and on such terms, including as to remuneration, as they think fit.

Director Independence and Financial Experts

Upon the consummation of the Business Combination, we expect that a majority of the Board of Directors will be independent under Nasdaq Capital Market’s listing standards. The independent directors, as determined under Nasdaq Capital Market Listing Rules are Jrang Teen, Shuding Zeng and Zhengcai Liu.

Our independent directors will have regularly scheduled meetings at which only independent directors are present.

Any affiliated transactions will be on terms no less favorable to us than could be obtained from independent parties. Our board of directors will review and approve all affiliated transactions with any interested director abstaining from such review and approval.

Zhengcai Liu qualifies as an “audit committee financial experts” as defined under the rules and regulations of the SEC.

Officer Compensation Following the Business Combination

The policies of New VIWO with respect to the compensation of its executive officers following the Business Combination are expected to be administered by the board of directors of New VIWO in consultation with its compensation committee and governed by employment agreements to be entered into with such officers individually. New VIWO may also rely on data and analyses from third parties, such as compensation consultants, in connection with its compensation programs. New VI